FDA News Digest
February 25, 2008
_____________________________________
IN THIS WEEK'S ISSUE
» News
-- Treatment Licensed to Help Control, Prevent Bleeding in Hemophilia A Patients
-- Companies, Executives Prohibited from Making Products with Disease Claims
» Consumer Health Information
FDA has licensed a treatment for hemophilia A, a rare, hereditary blood-clotting disorder that affects approximately 15,000 individuals -- almost exclusively males -- in the
Companies, Executives Prohibited from Making Products with Disease Claims
Brownwood Acres Foods Inc., Cherry Capital Services Inc. (doing business as Flavonoid Sciences), and two company executives have signed a consent decree that effectively prohibits the companies and their executives from manufacturing and distributing any products with label claims to cure, treat, mitigate or prevent diseases. The companies have agreed to remove drug and unauthorized health claims from their labels, brochures, and Web sites, as well as references to other Web sites that contain such claims.
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01800.html
To view an archive of recent FDA news releases, go to
To access the RSS feed of FDA news releases, go to http://www.fda.gov/bbs/topics/news/rssPress.xml. [What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
_____________________________________________
SAFETY ALERTS/RECALLS
› Mayfield Vanilla Classic Ice Cream, half-gallon size
Reason for recall: pecans in product not declared on label
› Pierre's Homestyle Dutch Chocolate Ice Cream, 56-oz. size
Reason for recall: may contain peanut component not declared on label
products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.
To access the RSS feed of FDA recalls information, go to http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml
[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
__________________________________________________________________
UPCOMING PUBLIC MEETINGS
Feb. 27-28 -- Anti-Infective Drugs Advisory Committee
Under discussion: two pending applications for skin/skin structure infection treatments
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E8-343.htm
March 11 -- Anesthetic and Life Support Drugs Advisory Committee
Under discussion: pending application for a new drug
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E8-1239.htm
March 12-13 -- Oncologic Drugs Advisory Committee
Under discussion: pending license application for a biological treatment
Location: Gaithersburg, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E8-1295.htm
For a complete list of FDA meetings, seminars, and other public events, go to
› Icy Hot Heat Therapy Products Recalled
http://www.fda.gov/consumer/updates/icyhot_recall021908.html
› Charges Filed in Contaminated Pet Food Scheme
http://www.fda.gov/consumer/updates/pet_food021908.html
Thanks for subscribing to FDA News Digest.
Comments about FDA News Digest?
Send an e-mail to fdanewsdigest@xxxxxxxxxv.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420